David Smoller

Immunophotonics, Inc. develops proprietary novel drug product for use in a minimally invasive therapeutic cancer vaccine. Its vaccine process under development, inCVAX, is a two injection procedure into one or more selected tumors: The first injection is a needle with an optical fiber (coupled to a laser) that heats selected tumor(s) locally; The second injection is experimental drug product, a proprietary synthesized carbohydrate polymer, that is intended to recruit and activate antigen-presenting cells, potentially triggering a cascade that leads to a systemic anti-tumor immune response. The company was founded by Lu Alleruzzo and Tomas Hode in 2009 and is headquartered in St. Louis, MI.

Part of Incyte Corp., Genome Systems, Inc. is a company that researches and develops biotechnical products. The company is based in St. Louis, MO. The company was founded by David Adam Smoller. Genome Systems was acquired by Incyte Corp. on July 23, 1996 for $7.33 million.

Apse, Inc. offers technology and strategy services. It develops technology that will allow the cost efficient production of RNA for broad acre topical RNAi uses in agriculture. The company was founded by Juan Arhancet in 2011 and is headquartered in St. Louis, MO.

Canopy Biosciences LLC engages in the provision of products and services for gene editing, gene expression analysis and regulation, and bioprocessing. It offers crispr complete kits, mirna crispr knockout kits, clia certified services, compbio, mirna mimics, and cho complete. The company was founded by David Adam Smoller, Edward J. Weinstein and Crystal Winkeler in 2016 and is headquartered in St. Louis, MO.

Cultivation Capital LLC (Cultivation Capital) is a venture capital firm founded in 2012 by Brian Matthews, Cliff Holekamp, Jim McKelvey, Kyle Welborn, and Peter Esparrago. The firm is headquartered in St. Louis, Missouri.

Thompson Street Capital Managers LLC (Thompson Street Capital) is a private equity subsidiary of Thompson Street Capital Partners LLC, founded in 2000 by James A. Cooper and Peter Finley. The firm is headquartered in St. Louis, Missouri.

BioGenerator (Venture Capital) (BioGenerator) is a venture capital subsidiary of BioGenerator founded in 2003. The firm is headquartered in St. Louis, Missouri.

Solis Agrosciences, Inc. is a plant sciences company located in the 39N Innovation District. The American company offers technology and research services to agricultural innovators with the goal of designing and delivering new biotech plant traits in multiple crops using their proprietary Plant Pipeline as a Service (PPaaS™) for gene-edited and transgenic plant generation and characterization. Solis has a team of experienced scientists, entrepreneurs, and agtech leaders to support research needs and accelerate agricultural innovation to solve food and climate challenges. The company was founded by Charlie W. Bolten and the CEO is Tom Cohen.

Vector Laboratories, Inc. develops, manufactures and markets labeling and detection reagents for immunohistochemistry, immunofluorescence, DNA/RNA and glycobiology. Its products include neuronal tracers, ultrapure immunological products, and novel reagents for detection and isolation of nucleic acids, fusion proteins and carbohydrates. The company was founded in 1976 and is headquartered in Burlingame, CA.

Part of Revvity, Inc., Sage Labs, Inc. is a company that provides animal research models and support services. The company is based in St. Louis, MO. Sage Labs was acquired by Horizon Discovery Group Ltd., part of Revvity, Inc. from December 24, 2020 on September 29, 2014 for $48.05 million.